-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, STaiPf6YN/hv0Mx/6CZUD47sNMKadL0gM2dGjHfnJxo+/lsxmacWcH6/hHYnz1yf o0Byok2WMa1T2ueDyAhGHA== 0000894189-05-002600.txt : 20050927 0000894189-05-002600.hdr.sgml : 20050927 20050927150742 ACCESSION NUMBER: 0000894189-05-002600 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050731 FILED AS OF DATE: 20050927 DATE AS OF CHANGE: 20050927 EFFECTIVENESS DATE: 20050927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADVISORS SERIES TRUST CENTRAL INDEX KEY: 0001027596 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-07959 FILM NUMBER: 051105200 BUSINESS ADDRESS: STREET 1: U.S BANCORP FUND SERVICES, LLC STREET 2: 615 E MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 414-765-5344 MAIL ADDRESS: STREET 1: 615 E MICHIGAN STREET STREET 2: MK-WI-LC2 CITY: MILWAUKEE STATE: WI ZIP: 53202 N-Q 1 castlerock_nq.htm CASTLEROCK FUND QUARTERLY NOTICE OF PORTFOLIO HOLDINGS CastleRock Fund Quarterly Notice of Portfolio Holdings


As filed with the Securities and Exchange Commission on September 27, 2005



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM N-Q
 
 
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY
 




Investment Company Act file number 811-07959



Advisors Series Trust
(Exact name of registrant as specified in charter)



615 E. Michigan St.
Milwaukee, WI 53202 
(Address of principal executive offices) (Zip code)



Eric M. Banhazl
Advisors Series Trust
2020 East Financial Way, Suite 100
Glendora, CA 91741 
(Name and address of agent for service)



(414) 765-5340
(Registrant's telephone number, including area code)



Date of fiscal year end: October 31, 2005



Date of reporting period: July 31, 2005 




 
Item 1. Schedule of Investments.

 
CastleRock Fund
       
Schedule of Investments at July 31, 2005 (Unaudited)
       
         
COMMON STOCKS - 91.13%
 
Shares
 
Market Value
         
Aerospace & Defense - 1.83%
       
Honeywell International, Inc. (a)
 
3,000
$
117,840
         
Airlines - 6.60%
       
Southwest Airlines Co. (a)
 
30,000
 
425,700
         
Automobiles - 1.65%
       
Harley-Davidson, Inc. (a)
 
2,000
 
106,380
         
Capital Markets - 5.07%
       
Merrill Lynch & Co., Inc. (a)
 
2,500
 
146,950
Morgan Stanley (a)
 
3,400
 
180,370
       
327,320
         
Chemicals - 2.36%
       
Sensient Technologies Corp. (a)
 
8,000
 
152,080
         
Commercial Banks - 1.70%
       
North Fork Bancorporation, Inc. (a)
 
4,000
 
109,560
         
Computers & Peripherals - 1.94%
       
Lexmark International, Inc. - Class A (a)(b)
 
2,000
 
125,400
         
Diversified Financial Services - 2.45%
       
J.P. Morgan Chase & Co. (a)
 
4,500
 
158,130
         
Energy Equipment & Services - 2.94%
       
Tidewater, Inc. (a)
 
4,700
 
189,739
         
Food & Staples Retailing - 1.53%
       
Wal-Mart Stores, Inc. (a)
 
2,000
 
98,700
         
Health Care Equipment & Supplies - 1.77%
       
Biomet, Inc. (a)
 
3,000
 
114,390
         
Hotels, Restaurants & Leisure - 1.94%
       
Ruby Tuesday, Inc. (a)
 
5,000
 
125,100
         
Industrial Conglomerates - 4.53%
       
Tyco International Ltd. (a)(c)
 
9,600
 
292,512
         
Insurance - 18.81%
       
American International Group, Inc. (a)
 
2,500
 
150,500
Hilb Rogal & Hobbs Co. (a)
 
4,000
 
135,560
MBIA, Inc. (a)
 
10,300
 
625,622
Transatlantic Holdings, Inc.
 
5,100
 
301,869
       
1,213,551
         
IT Services - 4.62%
       
Affiliated Computer Services, Inc. - Class A (b)
 
2,800
 
139,916
First Data Corp. (a)
 
3,500
 
143,990
SunGard Data Systems, Inc. (b)
 
400
 
14,356
       
298,262
         
Machinery - 1.09%
       
Dover Corp. (a)
 
1,700
 
70,142
         
Media - 5.36%
       
Gannett Co, Inc.
 
2,000
 
145,920
The Walt Disney Co. (a)
 
7,800
 
199,992
       
345,912
         
Personal Products - 1.22%
       
Avon Products, Inc. (a)
 
2,400
 
78,504
         
Pharmaceuticals - 6.40%
       
Bristol-Myers Squibb Co. (a)
 
7,500
 
187,350
Merck & Co., Inc. (a)
 
3,000
 
93,180
Pfizer, Inc. (a)
 
5,000
 
132,500
       
413,030
         
Software - 4.00%
       
Microsoft Corp. (a)
 
4,500
 
115,245
Symantec Corp. (a)(b)
 
6,500
 
142,805
       
258,050
         
Specialty Retail - 8.07%
       
Home Depot, Inc. (a)
 
4,000
 
174,040
Lowe's Cos., Inc. (a)
 
3,100
 
205,282
TJX Cos., Inc. (a)
 
6,000
 
141,060
       
520,382
         
Textiles, Apparel & Luxury Goods - 2.08%
       
Jones Apparel Group, Inc. (a)
 
4,400
 
134,508
         
Thrifts & Mortgage Finance - 3.17%
       
The PMI Group, Inc. (a)
 
5,000
 
204,750
         
TOTAL COMMON STOCKS (Cost $5,723,516)
     
5,879,942
         
SHORT-TERM INVESTMENTS - 23.00%
       
         
AIM STIT-Liquid Assets Portfolio
 
1,483,965
 
1,483,965
(Cost $1,483,965)
       
         
Total Investments in Securities (Cost $7,207,481) - 114.13%
     
7,363,907
Liabilities in Excess of Other Assets - (14.13)%
     
(911,721)
NET ASSETS - 100.00%
   
$
6,452,186
         
         
(a) Security is subject to written call option(s).
       
(b) Non-income producing security.
       
(c) U.S. traded security of a foreign issuer.
       
         
         
CastleRock Fund
       
Schedule of Call Options Written at July 31, 2005 (Unaudited)
       
         
Underlying Security/Expiration Date/Exercise Price
 
Contracts
 
Market Value
         
American International Group, Inc.
       
Expiration: January, 2007, Exercise Price: $60.00
 
25
$
(19,750)
Avon Products, Inc.
       
Expiration: August, 2005, Exercise Price: $35.00
 
8
 
(80)
Avon Products, Inc.
       
Expiration: October, 2005, Exercise Price: $35.00
 
8
 
(460)
Avon Products, Inc.
       
Expiration: January, 2006, Exercise Price: $37.50
 
8
 
(460)
Biomet, Inc.
       
Expiration: October, 2005, Exercise Price: $37.50
 
15
 
(3,600)
Biomet, Inc.
       
Expiration: January, 2006, Exercise Price: $35.00
 
15
 
(7,800)
Bristol-Myers Squibb Co.
       
Expiration: August, 2005, Exercise Price: $25.00
 
10
 
(300)
Bristol-Myers Squibb Co.
       
Expiration: September, 2005, Exercise Price: $25.00
 
25
 
(1,750)
Bristol-Myers Squibb Co.
       
Expiration: December, 2005, Exercise Price: $25.00
 
40
 
(4,800)
Dover Corp.
       
Expiration: September, 2005, Exercise Price: $35.00
 
10
 
(6,450)
Dover Corp.
       
Expiration: December, 2005, Exercise Price: $35.00
 
7
 
(4,725)
First Data Corp.
     
 
Expiration: November, 2005, Exercise Price: $37.50
 
17
 
(7,650)
First Data Corp.
       
Expiration: November, 2005, Exercise Price: $40.00
 
18
 
(4,770)
Harley-Davidson, Inc.
       
Expiration: August, 2005, Exercise Price: $42.50
 
20
 
(21,600)
Hilb Rogal & Hobbs Co.
       
Expiration: August, 2005, Exercise Price: $35.00
 
20
 
(750)
Hilb Rogal & Hobbs Co.
       
Expiration: October, 2005, Exercise Price: $35.00
 
20
 
(1,950)
Home Depot, Inc.
       
Expiration: August, 2005, Exercise Price: $40.00
 
10
 
(3,500)
Home Depot, Inc.
       
Expiration: November, 2005, Exercise Price: $40.00
 
10
 
(4,600)
Home Depot, Inc.
       
Expiration: January, 2006, Exercise Price: $40.00
 
10
 
(5,200)
Honeywell International, Inc.
       
Expiration: September, 2005, Exercise Price: $35.00
 
15
 
(6,600)
Honeywell International, Inc.
       
Expiration: December, 2005, Exercise Price: $35.00
 
15
 
(7,500)
Jones Apparel Group, Inc.
       
Expiration: August, 2005, Exercise Price: $30.00
 
34
 
(3,485)
Jones Apparel Group, Inc.
       
Expiration: January, 2006, Exercise Price: $30.00
 
5
 
(1,200)
Jones Apparel Group, Inc.
       
Expiration: January, 2006, Exercise Price: $35.00
 
5
 
(275)
J.P. Morgan Chase & Co.
       
Expiration: August, 2005, Exercise Price: $35.00
 
15
 
(825)
J.P. Morgan Chase & Co.
       
Expiration: September, 2005, Exercise Price: $35.00
 
15
 
(1,425)
J.P. Morgan Chase & Co.
       
Expiration: December, 2005, Exercise Price: $35.00
 
15
 
(2,475)
Lexmark International, Inc. - Class A
       
Expiration: October, 2005, Exercise Price: $65.00
 
10
 
(2,250)
Lexmark International, Inc. - Class A
       
Expiration: January, 2006, Exercise Price: $65.00
 
10
 
(3,700)
Lowe's Cos., Inc.
       
Expiration: January, 2006, Exercise Price: $60.00
 
1
 
(845)
MBIA, Inc.
       
Expiration: August, 2005, Exercise Price: $55.00
 
30
 
(18,750)
MBIA, Inc.
       
Expiration: November, 2005, Exercise Price: $55.00
 
20
 
(15,600)
MBIA, Inc.
       
Expiration: January, 2006, Exercise Price: $55.00
 
27
 
(23,490)
MBIA, Inc.
       
Expiration: January, 2007, Exercise Price: $60.00
 
26
 
(24,700)
Merck & Co., Inc.
       
Expiration: January, 2006, Exercise Price: $30.00
 
30
 
(7,650)
Merrill Lynch & Co., Inc.
       
Expiration: August, 2005, Exercise Price: $55.00
 
10
 
(3,800)
Merrill Lynch & Co., Inc.
       
Expiration: October, 2005, Exercise Price: $55.00
 
15
 
(7,200)
Microsoft Corp.
       
Expiration: August, 2005, Exercise Price: $25.00
 
20
 
(1,500)
Microsoft Corp.
       
Expiration: September, 2005, Exercise Price: $25.00
 
25
 
(2,375)
Morgan Stanley
       
Expiration: January, 2006, Exercise Price: $45.00
 
10
 
(9,150)
Morgan Stanley
       
Expiration: January, 2006, Exercise Price: $50.00
 
14
 
(7,350)
Morgan Stanley
       
Expiration: January, 2007, Exercise Price: $55.00
 
10
 
(5,450)
North Fork Bancorporation, Inc.
       
Expiration: September, 2005, Exercise Price: $27.50
 
20
 
(2,250)
North Fork Bancorporation, Inc.
       
Expiration: November, 2005, Exercise Price: $27.50
 
10
 
(1,450)
North Fork Bancorporation, Inc.
       
Expiration: January, 2006, Exercise Price: $27.50
 
10
 
(1,825)
Pfizer, Inc.
       
Expiration: September, 2005, Exercise Price: $25.00
 
20
 
(4,000)
Pfizer, Inc.
       
Expiration: September, 2005, Exercise Price: $27.50
 
6
 
(240)
Pfizer, Inc.
       
Expiration: December, 2005, Exercise Price: $25.00
 
12
 
(2,940)
Pfizer, Inc.
       
Expiration: December, 2005, Exercise Price: $27.50
 
12
 
(1,320)
Ruby Tuesday, Inc.
       
Expiration: September, 2005, Exercise Price: $25.00
 
10
 
(850)
Ruby Tuesday, Inc.
       
Expiration: October, 2005, Exercise Price: $22.50
 
10
 
(3,075)
Ruby Tuesday, Inc.
       
Expiration: October, 2005, Exercise Price: $25.00
 
20
 
(2,650)
Ruby Tuesday, Inc.
 
 
   
Expiration: January, 2006, Exercise Price: $25.00
 
10
 
(2,075)
Sensient Technologies Corp.
       
Expiration: August, 2005, Exercise Price: $20.00
 
25
 
(437)
Sensient Technologies Corp.
       
Expiration: October, 2005, Exercise Price: $20.00
 
25
 
(1,313)
Sensient Technologies Corp.
       
Expiration: January, 2006, Exercise Price: $20.00
 
30
 
(2,325)
Southwest Airlines Co.
       
Expiration: September, 2005, Exercise Price: $15.00
 
126
 
(2,520)
Southwest Airlines Co.
       
Expiration: January, 2006, Exercise Price: $15.00
 
174
 
(12,180)
Symantec Corp.
       
Expiration: August, 2005, Exercise Price: $20.00
 
25
 
(5,250)
Symantec Corp.
       
Expiration: October, 2005, Exercise Price: $20.00
 
20
 
(5,400)
Symantec Corp.
       
Expiration: January, 2006, Exercise Price: $20.00
 
20
 
(6,800)
The PMI Group, Inc.
       
Expiration: January, 2006, Exercise Price: $40.00
 
50
 
(16,375)
The Walt Disney Co.
       
Expiration: August, 2005, Exercise Price: $25.00
 
20
 
(2,000)
The Walt Disney Co.
       
Expiration: September, 2005, Exercise Price: $25.00
 
20
 
(2,300)
The Walt Disney Co.
       
Expiration: October, 2005, Exercise Price: $25.00
 
19
 
(2,613)
The Walt Disney Co.
       
Expiration: January, 2006, Exercise Price: $25.00
 
19
 
(3,515)
Tidewater, Inc.
       
Expiration: August, 2005, Exercise Price: $35.00
 
15
 
(8,325)
Tidewater, Inc.
       
Expiration: October, 2005, Exercise Price: $35.00
 
15
 
(9,225)
Tidewater, Inc.
       
Expiration: January, 2006, Exercise Price: $35.00
 
17
 
(11,985)
TJX Cos., Inc.
       
Expiration: September, 2005, Exercise Price: $22.50
 
30
 
(4,350)
TJX Cos., Inc.
       
Expiration: October, 2005, Exercise Price: $22.50
 
30
 
(5,100)
Tyco International Ltd.
       
Expiration: September, 2005, Exercise Price: $30.00
 
20
 
(3,500)
Tyco International Ltd.
       
Expiration: October, 2005, Exercise Price: $30.00
 
21
 
(4,095)
Tyco International Ltd.
       
Expiration: January, 2006, Exercise Price: $30.00
 
35
 
(8,925)
Tyco International Ltd.
       
Expiration: January, 2007, Exercise Price: $35.00
 
20
 
(4,600)
Wal-Mart Stores, Inc.
       
Expiration: September, 2005, Exercise Price: $47.50
 
20
 
(4,900)
         
Total Call Options Written (Proceeds $366,207)
   
$
(408,498)
         
         
 
For certain federal income tax information, as well as other information regarding securities valuation and other significant accounting policies, please refer to the footnotes to the Fund’s most recent semi-annual or annual report.
 

 
Item 2. Controls and Procedures.
 
(a)  
The Registrant’s President/Chief Executive Officer and Treasurer/Chief Financial Officer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “1940 Act”)) are effective as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rules 15d-15(b) under the Securities Exchange Act of 1934, as amended.

(b)  
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the Registrant's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.

 
Item 3. Exhibits.
 
Separate certifications for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)). Filed herewith.



 


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


(Registrant)  Advisors Series Trust                              

By (Signature and Title)  /s/Eric M. Banhazl                
Eric M. Banhazl, President

Date   9/22/05                                                                    



Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)* /s/Eric M. Banhazl               
Eric M. Banhazl, President

Date   9/22/05                                                                     

By (Signature and Title)* /s/Douglas G. Hess             
Douglas G. Hess, Treasurer

Date   9/22/05                                                                     

* Print the name and title of each signing officer under his or her signature.

EX-99.CERT 2 certs.htm CERTIFICATIONS Certifications


 
CERTIFICATION
 
I, Eric M. Banhazl, certify that:

1.  
I have reviewed this report on Form N-Q of Advisors Series Trust;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.  
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) for the registrant and have:

(a)  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  
[Omit];

(c)  
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d)  
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.  
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b)  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Date:   9/22/05                              
/s/Eric M. Banhazl                                  
 
Eric M. Banhazl, President



 
CERTIFICATION
 
I, Douglas G. Hess, certify that:

1.  
I have reviewed this report on Form N-Q of Advisors Series Trust;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.  
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) for the registrant and have:

(a)  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  
[Omit];

(c)  
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d)  
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.  
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b)  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
Date:   9/22/05                               
/s/Douglas G. Hess                             
 
Douglas G. Hess, Treasurer

-----END PRIVACY-ENHANCED MESSAGE-----